When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Incompatibilidade de Rh

Última revisão das evidências: 3 Sep 2026
Última atualização do tópico: 13 May 2026

Resumo

Definição

História e exame físico

Key diagnostic factors

  • presença de fatores de risco
Full details

Risk factors

  • história de feto Rhesus (Rh) D positivo em mãe RhD negativa
  • hemorragia feto-materna
  • procedimentos fetais invasivos
  • trauma placentário
  • aborto
  • multiparidade
  • omissão da imunoprofilaxia para rhesus D (RhD)
  • versão cefálica externa
  • gravidez molar
  • gravidez ectópica
Full details

Diagnostic tests

1st tests to order

  • tipo sanguíneo materno
  • exame de anticorpos no soro materno
Full details

Tests to consider

  • título de anticorpos séricos materno
  • tipo sanguíneo paterno
  • zigosidade paterna
  • ultrassonografia fetal
  • velocimetria Doppler da artéria cerebral média do feto (pico de velocidade sistólica)
  • tipagem sanguínea do feto (decorrente de amniocentese ou circulação materna)
  • avaliação direta de anemia fetal
  • teste de roseta
  • teste de Kleihauer-Betke/citometria de fluxo
Full details

Treatment algorithm

INITIAL

mãe RhD-negativa não sensibilizada

mãe RhD-negativa sensibilizada

ACUTE

neonato com doença hemolítica do neonato

Contributors

Authors

Andrea Shields, MD

Associate Professor of Obstetrics and Gynecology

Program Director Maternal Fetal Medicine Fellowship

Division of Maternal Fetal Medicine

University of Connecticut School of Medicine

Farmington, CT

Disclosures

AS declares that she has no competing interests.

Kristen Elmezzi, DO

Maternal Fetal Medicine Fellow

Division of Maternal Fetal Medicine

University of Connecticut School of Medicine

Farmington, CT

Disclosures

KE declares that she has no competing interests.

Acknowledgements

Dr Andrea D. Shields and Dr Kristen Elmezzi would like to gratefully acknowledge Dr Andrew D. Hull, Dr Karen Fung-Kee-Fung, and Dr Felipe Moretti, previous contributors to this topic.

Disclosures

KFKF is an author of a reference cited in this topic. ADH, KFKF, and FM declare that they have no competing interests.

Peer reviewers

Alan Cameron, MD

Honorary Professor of Medicine

University of Glasgow

Glasgow

UK

Disclosures

AC is an author of several references cited in this topic.

Liakat Ali Parapia, MD, FRCP

Consultant Hematologist

Bradford Teaching Hospitals NHS Trust

Yorkshire Clinic

Bingley

Bradford

UK

Disclosures

LAP declares that he has no competing interests.

Kenneth J. Moise, Jr., MD

Professor of Obstetrics and Gynecology

Texas Children's Fetal Center

Baylor College of Medicine/Texas Children's Hospital

Houston, TX

Disclosures

KJM declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

American College of Obstetrics and Gynecology. ACOG practice bulletin no. 181: prevention of Rh D alloimmunization. Obstet Gynecol. 2017 Aug;130(2):e57-70. Abstract

Brennand J, Cameron A. Fetal anaemia: diagnosis and management. Best Pract Res Clin Obstet Gynaecol. 2008 Feb;22(1):15-29. Abstract

Visser GHA, Thommesen T, Di Renzo GC, et al. FIGO/ICM guidelines for preventing Rhesus disease: a call to action. Int J Gynaecol Obstet. 2021 Feb;152(2):144-7.Full text  Abstract

American Congress of Obstetrics and Gynecology. ACOG practice bulletin no. 192: management of alloimmunization during pregnancy. Obstet Gynecol. 2018 Mar;131(3):e82-90. Abstract

Qureshi H, Massey E, Kirwan D, et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med. 2014 Feb;24(1):8-20.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Incompatibilidade de Rh images
  • Differentials

    • Hidropisia fetal não imune
    • Infecção por parvovírus
    • Doença hemolítica não relacionada ao RhD
    More Differentials
  • Guidelines

    • Ectopic pregnancy and miscarriage: diagnosis and initial management
    • Guideline for the investigation and management of red cell antibodies in pregnancy
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer